ebook img

Affinity Modification Of Biopolymers PDF

278 Pages·2017·14.077 MB·English
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Affinity Modification Of Biopolymers

Affinity Modification of Biopolymers Authors Dmitri G. Knorre Valentin V. Vlassov Institute of Bioorganic Chemistry U.S.S.R. Academy of Sciences Novosibirsk, Soviet Union CRC Press Taylor & Francis Group Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business First published 1989 by CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 Reissued 2018 by CRC Press © 1989 by CRC Press, Inc. CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and information, but the author and publisher cannot assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint. Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers. For permission to photocopy or use material electronically from this work, please access www.copyright.com (http://www.copyright. com/) or contact the Copyright Clearance Center, Inc. (CCC), 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400. CCC is a not- for-profit organization that provides licenses and registration for a variety of users. For organizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged. Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent to infringe. Library of Congress Cataloging-in-Publication Data Knorre, D. G. (Dmitri Georgievich) Affinity modification of biopolymers. Bibliography: p. Includes index. 1. Affinity labeling. 2. Biopolymers—Affinity labeling. 3. Proteins—Analysis. 4. Nucleic acids— Analysis. I. Vlassov, Valentin Viktorovich. II. Title. QP519.9.A37K66 1988 574.19’285 88-2883 ISBN 0-8493-6925-8 A Library of Congress record exists under LC control number: 88002883 Publisher’s Note The publisher has gone to great lengths to ensure the quality of this reprint but points out that some imperfections in the original copies may be apparent. Disclaimer The publisher has made every effort to trace copyright holders and welcomes correspondence from those they have been unable to contact. ISBN 13: 978-1-315-89046-3 (hbk) ISBN 13: 978-1-351-06956-4 (ebk) Visit the Taylor & Francis Web site at http://www.taylorandfrancis.com and the CRC Press Web site at http://www.crcpress.com PREFACE The fundamental property of proteins and nucleic acids is the ability to bind definite low molecular weight ligands or other biopolymers. This phenomenon is usually called recog- nition. It is the basis of a number of the most important biological events. Thus, self- assembly of complicated structures such as ribosomes, chromatins, and viruses proceeds due to mutual recognition of nucleic acids and proteins constituting these structures. The first step of all numerous enzymatic reactions is the specific binding of substrates to the active center of the respective enzyme. Hormones and neurotransmitters interact with specific receptors of cell membranes giving rise to a definite biological response of the target cell. Recognition of antigens by antibodies or receptors of T lymphocytes is one of the crucial steps of the action of the immune system. The specific interaction of nucleic acid strands with complementary sequences of nucleotides is the foundation of the mechanism of storage, multiplication, and expression of the genetic information. This incomplete list of phenomena concerning the formation of biological structures, cell metabolism, regulation, nerve impulse transmission, heredity, and immune response clearly demonstrates the extreme significance of recognition processes in biological systems. Recognition is not usually followed by any changes of the chemical structure of a bio- polymer. Thus, enzymatic conversion of substrates is not accompanied by any alteration of the chemical structure of the enzyme if transient covalent binding of certain fragments of substrates to enzymes in the course of formation of labile intermediates is not taken into account. This permits the repeated use of the same biopolymer molecule. At the same time, the absence of chemical consequences of recognition makes it difficult to determine the area of biopolymer participating in the specific complex formation. Modern biochemistry demonstrates that it is usually possible to introduce changes in the ligand structure which do not severely damage the ability of the structure to be recognized by the respective biopolymer. This means that in the modified ligand the points are touched which are not critically essential for the specific complex formation. In particular, some reactive groups may be inserted into the ligand. In this case, the specific complex formation may result in the chemical reaction between this reactive group and biopolymer residue adjacent to the recognition area. This reaction should strongly predominate over reactions of the same compound with similar residues of biopolymer due to close contact between reaction partners. Therefore, selective chemical modification of a definite area of biopolymer close to the region of specific interaction may be performed. As the selectivity is achieved due to affinity of the reactive ligand, the process may be called affinity modification of biopolymers. As a general approach to a specific attack of enzymes and other functional proteins, affinity modification was first realized by B. R. Baker.' As the region where recognition and subsequent catalytic transformation of a substrate proceeds is usually referred to as active site (active center), the approach as well as his book were called Design of Active Site Directed Irreversible Inhibitors. About the same time, N. I. Grineva started to elaborate the similar approach to selective modification of nucleic acids. It was proposed to attach reactive groups to oligonucleotides with sequences complementary to a definite region of the target nucleic acid. The method was called complementary addressed modification.2•3 Oligonucleotide moiety of such re- agents may be considered as an address directing the reactive group to the desired fragment of nucleic acid subjected to modification. In the 2 following decades affinity modification was widely used to study enzymes, receptors, immunoglobulins, nucleoproteins, and other biopolymers and complexes. To more easily localize the residues introduced into biopolymers by means of affinity modification, reagents were usually supplied with radioactive labels. Therefore, the method is referred to as affinity labeling. It has become one of the powerful tools of investigating structure and function of proteins, nucleic acids, and complexes of proteins and nucleic acids. Pharma- cological applications of the approach were discussed in a set of papers. Different aspects of affinity labeling were considered in some reviews. A special volume of Methods in Enzymology' was devoted to this method. In 1981, the Federation of the European Bio- chemical Society (FEBS) organized special practical courses for affinity labeling in the Institute of Organic Chemistry in Novosibirsk, U.S.S.R. The lectures given by leading scientists in the field were edited as a separate book.' The goal of this book is to give a systematic description of the main principles of affinity modification and applications, consideration of possibilities, and restrictions of the method. Modification within specific complexes is a special case of chemical modification which is widely used in the nonaddressed version in biochemistry and related areas. Therefore, we have included in the first introductory chapter of the book general considerations of chemical modifications of biopolymers and the application of biopolymers. The main principles and possibilities of affinity modification are illustrated by a great number of experimental works covering the fields of biochemistry, molecular biology, pharmacology, and immunochemistry. Therefore, the primary knowledge of the main con- cepts of these disciplines by the readers is suggested. However, short descriptions of bio- and immunochemical systems considered in the experimental examples are given in the text. Among numerous types of specific interactions, the recognition of nucleic acids and the components by proteins attracts the greatest attention of scientists. Several hundred enzymes deal with nucleotides, nucleosidedi-, and triphosphates, and nucleotide coenzymes as sub- strates and effectors. Almost all proteins and nucleoproteides participating in the storage, multiplication, and expression of genetic information interact specifically with nucleic acids. Among them are DNA and RNA polymerases, ribosomes, translation and transcription factors, enzymes of the reparation and recombination systems, different DNA unwinding proteins, and aminoacyl-tRNA-synthetases. Therefore, some preference is given in this book to affinity labeling of biopolymers with reactive derivatives of nucleic acids and components. A special section is devoted to this group of compounds and the results obtained by affinity modification of polymerases of nucleic acids, ribisomes, and aminoacyl-tRNA-synthetases are given in more detail as compared with the numerous number of other systems discussed in this book. It is impossible to represent the complete survey of the several thousand scientific papers dealing with affinity modification. At the same time, we tried to present all the reviews concerning the problems and achievements of the last few years. THE AUTHORS Dmitri G. Knorre, Professor, is the Director of the Novosibirsk Institute of Bioorganic Chemistry of the Siberian Division of the U.S.S.R. Academy of Sciences. He was a student of Mendeleev Institute of Technology in Moscow. As a postgraduate student, he worked at the Institute of Chemical Physics, and in 1951 he was awarded the doctor's degree in chemistry. In 1968, he became a correspondent member and, in 1981, full member of the U.S.S.R. Academy of Sciences. Professor Knorre's interest in biochemistry dates back to 1956 when, still in Moscow, he started the first exercises in bioorganic chemistry of peptides and then in nucleic acids chemistry. In 1961, he moved to the Institute of Organic Chemistry in Novosibirsk, and, until 1984, headed the Department of Biochemistry in this institute. Since 1984, Professor Knorre has been the Director of a newly formed Institute of Bioorganic Chemistry in Novosibirsk. His scientific interests were concentrated around chemical modification of biopolymers, mainly affinity modification of nucleic acids with reactive derivatives of complementary oligonucleotides (complementary addressed modification of nucleic acids). His main achieve- ments are the elucidation of a mechanism of phosphorylation including some steps of ol- igonucleotide synthesis, design of a series of new nucleoside triphosphate derivatives, iden- tification of ribosomal proteins involved in interaction with transfer and messenger RNAs by means of affinity modification with reactive derivatives of oligo- and polynucleotides. Being the Head of the Chair of Molecular Biology at the Novosibirsk State University, Professor Knorre holds lectures in physical chemistry, molecular biology, bioorganic chem- istry, and biochemistry. Valentin V. Vlassov is the Deputy Director of the Novosibirsk Institute of Bioorganic Chemistry. Being a student of the Novosibirsk State University, he started experimental work in Prof. D. G. Knorre's laboratory in the Institute of Organic Chemistry in 1967. In 1972, he received a doctor's degree. Since 1982, Dr. Vlassov has been a head of the Laboratory of Biochemistry of Nucleic Acids, studying biochemical and biological appli- cations of oligonucleotide derivatives. A basic interest of Dr. Vlassov concerns the chemical modification of biopolymers with special regard to specific modifications of nucleic acids. His main contributions to this field have been to develop new approaches for the investigation of tertiary structure and molecular interactions of RNAs by means of chemical modification with alkylating reagents, nitrogen mustard, and ethyl nitrosourea, to design new derivatives of oligo- and polynucleotides, and to study the possibility of using reactive oligonucleotide derivatives for sequence-specific modification of DNA, specific arrest of mRNA translation, and suppression of viruses multiplication. He holds lectures on chemistry of biopolymers at the Novosibirsk State University. TABLE OF CONTENTS Chapter 1 Molecular Recognition and Chemical Modification of Biopolymers — Two Main Com- ponents of Affinity Modification I.(cid:9) Molecular Recognition (cid:9) 1 A. Noncovalent Interactions and the Role in Molecular Recognition (cid:9) 1 B. Intramolecular Recognition in Biopolymers and the Role in the Formation of the Secondary and Tertiary Structure (cid:9) 6 C. Recognition in the Multisubunit Structure Formation: Multipeptide Complexes, Double-Stranded Nucleic Acids, and Nucleoproteins (cid:9) 10 D. Active Centers of Enzymes: Recognition of Substrates, Effectors, and Templates (cid:9) 14 E. Recognition in the Regulatory Processes (cid:9) 15 F. Recognition Processes at the Cell Surface (cid:9) 16 G. Recognition in the Immune System (cid:9) 19 II.(cid:9) Chemical Modification of Biopolymers (cid:9) 21 A. Derivatives of Biopolymers (cid:9) 23 B. Chemical Modification and Sequencing of Biopolymers (cid:9) 25 C. Mapping of Secondary and Tertiary Structure of Biopolymers by Chemical Modification (cid:9) 28 D. The Study of the Structure of Multisubunit Proteins and Complexes of Biopolymers (cid:9) 32 E. Bifunctional Reagents in the Study of the Structure and Complexes of Biopolymers (cid:9) 35 F. Chemical Modification in the Study of the Structure-Function Relations of Biopolymers (cid:9) 38 Chapter 2 Affinity Modification — Organic Chemistry I.(cid:9) Reactive Groups of Biopolymers (cid:9) 43 II. Reactive Groups of Affinity Reagents 45 A. Alkylating and Arylating Groups 45 B. Acylating, Sulfonylating, and Phosphorylating Groups 49 C. Carbonylic Compounds (cid:9) 51 D. Sulfhydryl and Disulfide Groups (cid:9) 53 E. Photoreactive Groups (cid:9) 54 F. Direct Photocross-Linking of Biopolymers with Specific Ligands (cid:9) 60 G. Suicide Reagents (cid:9) 64 H. Metal-Containing Groups (cid:9) 75 III.(cid:9) Design of Affinity Reagents (cid:9) 80 A. Targeting (Addressing) Structures of Affinity Reagents (cid:9) 80 B. General Approaches to the Synthesis of Affinity Reagents (cid:9) 87 C. Reactive Derivatives of Biopolymers (cid:9) 92 D. Reactive Derivatives of Nucleic Acids and Nucleic Acid Components (cid:9) 96 Chapter 3 Affinity Modification — Experimental Methods I.(cid:9) Introduction (cid:9) 109 II.(cid:9) Performance of Affinity Modification (cid:9) 109 A. General Procedures (cid:9) 109 B. Photoaffinity Modification (cid:9) 111 III.(cid:9) Experimental Procedures Used for Quantitative Investigation of Modification of Biopolymers (cid:9) 113 A. Extent of Modification (cid:9) 113 B. Inactivation of Biopolymer (cid:9) 116 IV.(cid:9) Determination of the Modification Points (cid:9) 118 A. Distribution of the Label Among Subunits in Multisubunit Systems (cid:9) 118 B. Determination of the Monomer Residues Modified (cid:9) 120 Chapter 4 Affinity Modification — Physical Chemistry I.(cid:9) Kinetics of Affinity Modification (cid:9) 129 A. The Simplest Scheme of Affinity Modification and the Range of Validity (cid:9) 129 B. Simultaneous Enzymatic and Affinity Modification Processes (cid:9)134 C. Simultaneous Modification of Several Independent Centers by the Same Reagent (cid:9) 136 D. Main Sources of Kinetic Complications in Affinity Modification (cid:9) 139 E. Affinity Modification with Unstable Reagents (cid:9) 142 F. Kinetics of Suicide Inhibition (cid:9) 145 G. Cooperative Effects in Affinity Modification (cid:9) 148 H. General Rules for Kinetic Treatment of Complicated Affinity Modification Processes (cid:9) 151 II.(cid:9) Quantitative Criteria of Affinity Modification (cid:9) 157 A. General Direct Criteria (cid:9) 157 B. Comparative Criteria of Affinity Modification (cid:9) 159 C. Dynamic Aspects of Affinity Modification (cid:9) 163 Chapter 5 Affinity Modification in Biochemistry, Biology, and Applied Sciences I.(cid:9) Introduction (cid:9) 165 II.(cid:9) Biochemical Applications of Affinity Modification (cid:9) 165 A. Structural Studies of the Active Centers of Enzymes (cid:9) 165 B. Cooperative Interactions in Enzymes as Revealed by Affinity Modification (cid:9) 170 C. Affinity Modification of the Nucleic Acid Polymerases (cid:9) 172 D. Affinity Modification as a Tool of the Study of Functional Topography of Ribosomes (cid:9) 177 E. Complementary Addressed Modification of Nucleic Acids (cid:9) 183 III.(cid:9) Biological, Pharmacological, and Therapeutic Applications of Affinity Modification (cid:9) 187 A. Localization of the Ligand Binding Sites (cid:9) 187 B. Affinity Modification of Enzymes in Biological Systems (cid:9) 188 C. Affinity Modification of Cell Receptors (cid:9) 190 D. Affinity Modification as an Approach to Produce Locally Damaged Biopolymers (cid:9) 192 E. Pharmacological and Therapeutic Applications of Affinity Modification (cid:9) 193 Appendix (cid:9) 197 References (cid:9) 225 Index (cid:9) 265 1 Chapter 1 MOLECULAR RECOGNITION AND CHEMICAL MODIFICATION OF BIOPOLYMERS — TWO MAIN COMPONENTS OF AFFINITY MODIFICATION I. MOLECULAR RECOGNITION A. Noncovalent Interactions and the Role in Molecular Recognition Recognition results in the formation of a specific complex of biopolymers and ligands. If the stability of a complex with a definite ligand significantly exceeds that of complexes with similar compounds we refer to the phenomenon as recognition of this ligand by the polymer under consideration. Complexes are formed by noncovalent interactions of some groups of biopolymers with respective groups of ligands. Three main types of interactions participate in recognition: electrostatic, hydrogen bonding, and hydrophobic interactions. Electrostatic interactions operate between groups bearing opposite charges. Amino acids bear a positive charge at the amino groups in a protonated state and a negative charge at the carboxylic group in an ionized state. However, the formation of a peptide bond results in the disappearance of these charges and the main polypeptide chain of protiens is electro- neutral with N-terminal NI-11- and C-terminal COO- residues. NH3-CH-CO (cid:9) NH-CH-CO-NH-CH-CO (cid:9) NH-CH-000 (I) R1(cid:9) Ri(cid:9) Ri.„1(cid:9) RN Therefore, the main carriers of electric charges in proteins are side-chain groups. These groups are presented in Table 1. On the contrary, the main chain of nucleic acids 0 -P-0 Basel 5-end R ,P 0 ‘0 Basel Base i+1 R R=H DNA(cid:9) 0' \0 ~Basen R=OH RNA OH R 3-e nd is a carrier of negative charge and, therefore, all nucleic acids are polyanions. Hydrogen bonding occurs between the polar X-H group (mainly X = N or 0) and electron pairs of nonbonding orbitals of F, 0, or N atoms. In hydrogen bonding, one of the bonded atoms is the donor, and the other is an acceptor of the proton. The peptide bond contains donor N-H and acceptor CC0 groups. Many amino acids (Table 1) bear hydrophilic residues

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.